Jul. 3 at 1:37 PM
$STAA new long. EVO ICL will become standard of care for myopia over LASIK within next few years. Company has had some operational issues which are being addressed including China inventory problems, tariffs, etc. But they should return to growth this year and chart looks like it bottomed imo.